Global next-generation biomanufacturing market was valued at USD 22.51 billion in 2023 and is projected to reach a market size of USD 43.31 billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 9.8%. Increasing biologics and biosimilars approvals, growing adoption of automation technologies among biomanufacturing vendors, increasing development and commercialization of digital bioreactors, increasing investment in R&D, and a vast range of advantages such as efficient bioproduction workflow with reduced cost, time, and labor are some factors majorly driving the growth of the next generation biomanufacturing market.
Industry Overview:
Biomanufacturing is the process involving the production of commercially important biomolecules by using biological systems for applications in medicines, industrial applications, and food and beverage processing. Natural sources including blood, animal cells, plant cells, and cultures of microbes, are often utilized to carry out biomanufacturing. Cells utilized in the production process can also be derived by genetic engineering techniques. The next generation of biomanufacturing plants has significantly increased the supply of biologic medicines owing to growing awareness among the people. Increasing commercialization and pipeline therapy product development owing to the growing prevalence of cancer, diabetes, and liver and kidney diseases worldwide are expanding the market growth. The adoption of automation technologies is gaining prominence in the biomanufacturing industry over the years as they provide streamlined control, greater speed, accuracy, and productivity. The growing number of biopharmaceutical companies across the world is anticipated to drive the next generation bio-manufacturing market in the coming years. Many companies are innovating products to enter the next-generation biomanufacturing market, which is likely to drive growth in the forthcoming years.
COVID-19 pandemic impact on Next Generation Biomanufacturing Market
The COVID-19 outbreak accelerated the development of vaccines in biomanufacturing industries. The development of advanced vaccines is likely to positively influence the growth of the biopharmaceutical industry post-pandemic. The bioprocessing of a few companies like GE Healthcare was severely impacted by the COVID-19 outbreak owing to the supply-demand gap. The company reported low revenue in bioprocess in 2020. At the same time, key market players like Danaher Corporation experienced high revenue growth owing to the high demand for bioprocess solutions products. COVID-19 outbreak has encouraged biomanufacturing companies in the United States to prioritize the development of vaccines, which is likely to fuel the market over the forecast market.
MARKET DRIVERS:
Increasing biologics and biosimilars approvals are driving the next generation biomanufacturing market
The number of development programs registered in FDA’s Biosimilar Biological Product Development Program is increasing, with 100 biosimilar development programs registered as of Q4 of Fiscal Year 2021. The rise in development and approvals of biosimilars over the past two years has led to a total of 33 approvals across 13 molecules to date. There has been a growth in the availability and usage of biosimilars which is on track to reduce drug costs by USD 100 billion over the next five years. Following the legislation that allows the FDA to approve biosimilars in the US, biological products similar to the reference product in terms of purity, potency, and safety are gradually entering the market. Such developments are augmenting the next-generation biomanufacturing market.
The growing adoption of automation technologies among biomanufacturing vendors is boosting the next generation biomanufacturing market
Automation technologies are increasingly gaining traction in the biomanufacturing industry over the years owing to their benefits in terms of speed, accuracy, and productivity. The automation systems market is growing rapidly with several companies investing and launching new automation solutions in the market to offer a more streamlined and centralized control. Biopharmaceuticals serve as an important part of the drug portfolio of pharmaceutical companies and thus, need to invest in automation and digitalization of biopharma research and development activities to discover new biopharmaceuticals efficiently and develop the resulting manufacturing processes.
Increasing development and commercialization of digital bioreactors and increasing investment in R&D are augmenting the market
The global next-generation biomanufacturing market is growing rapidly owing to the high investments from both public and private sectors to develop facilities equipped with advanced biomanufacturing instruments. Increased funding from private investors and the government for the development of next-generation biomanufacturing facilities is leading to rapid technological advancement in biomanufacturing products. Biopharmaceutical companies are adopting novel biomanufacturing strategies with an increased focus on balancing innovation in process design, efficiency, performance, speed, and cost. Rising commercialization, the growing biopharmaceutical sector, and the adoption of advanced technology as well as innovation across the globe are likely to accelerate the growth of the next-generation biomanufacturing market.
Efficient bioproduction workflow with reduced cost, time, and labor are some benefits boosting the next generation biomanufacturing market
Improved upstream and downstream processes, as well as the SUS technologies, enable a wide variety of facility options. These processes need fewer facility resources and can be moved and managed within smaller and less expensive facilities. There are a vast number of advantages associated with single-use products such as cost savings, increased flexibility in multi-product facilities, and reduced risk of product contamination.
MARKET RESTRAINTS:
The lack of skilled professionals in the next generation biomanufacturing market can be a restraining factor
Biopharmaceuticals present technological and operational challenges. Production of these complex molecules in a reliable matter at an industrial scale needs manufacturing capabilities of a previously unknown proficiency. The lack of an experienced talent pool in biologics is a primary challenge in the market expansion. Additionally, long process durations, costly raw materials, low yields, and the need for highly skilled experts for operations in production facilities can be some of the challenging factors.
Complex production steps and complexity in the process operational can slow down the growth of the Next Generation Biomanufacturing Market
Downstream processing consists of a series of unit operations involving different filtration and chromatography steps. Various factors are often related to limited capacity along with these multiple steps, which pose a challenge to product quality and productivity in downstream processing. In downstream processing, resin chromatography columns, have slow mass transfer rates and are oversized to allow for the higher flow rates to increase productivity. Such an oversizing strategy is often costly and inflexible. To increase productivity and flexibility, and decrease costs, there is a movement toward employing continuous processing, which in turn leads to other downstream processing challenges. Many technologies are addressing these downstream processing challenges but their application for biopharmaceutical production is still limited to large-scale production.
NEXT-GENERATION BIOMANUFACTURING MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 - 2030 |
|
Base Year |
2023 |
|
Forecast Period |
2024 - 2030 |
|
CAGR |
9.8% |
|
Segments Covered |
By Workflow Type, Application, End User, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Applikon Biotechnology BV, Thermo Fisher Scientific Inc., bbi-biotech GmbH, Danaher Corporation, Eppendorf AG, Esco Group of Companies,Meissner Filtration Products, Inc., Merck KGaA, PBS Biotech, Inc., Pierre Guerin, sartorius AG, Shanghai Bailun Biotechnology Co. Ltd, Solaris Biotechnology Srl, GEA Group Aktiengesellschaft, ZETA GmbH |
This research report on the global Next-Generation Biomanufacturing Market has been segmented and sub-segmented based on workflow type, application, end-user, and region.
Single-Use Upstream Biomanufaturing Workflow
Upstream Biomanufacturing Workflow
Downstream Biomanufaturing Workflow
Based on Workflow Type, the Next-Generation Biomanufacturing Market is bifurcated into Single-Use Upstream Biomanufaturing Workflow, Upstream Biomanufacturing Workflow, and Downstream Biomanufaturing Workflow. The Upstream Biomanufacturing Workflow segment held the dominant position in the global next-generation biomanufacturing market. A large number of high-cost equipment is involved in upstream biomanufacturing compared to downstream biomanufacturing. The Downstream Biomanufacturing Workflow segment is estimated to witness a high growth rate during the forecast period owing to continuous product innovations in the chromatography product lines and filtration systems used in downstream processing.
Monoclonal Antibodies
Recombinant protein
Vaccines
Hormones
Others
Based on Application, the Next-Generation Biomanufacturing Market is bifurcated into Monoclonal Antibodies, Recombinant proteins, Vaccines, Hormones, and Others. The Monoclonal Antibodies segment is estimated to dominate the next-generation biomanufacturing market owing to the high rate of product approval. The vaccines segment accounted for the second-largest share in the next generation biomanufacturing market owing to the recent coronavirus outbreak which led to considerable development of vaccines.
Biopharmaceutical Companies
Research Institutions
CMOs/CDMOs
Based on the End User, the Next-Generation Biomanufacturing Market is bifurcated into Biopharmaceutical Companies, Research Institutions, and CMOs/CDMOs. Based on end-user, the Biopharmaceutical Companies segment is anticipated to capture the largest revenue share in the next-generation biomanufacturing market. The rapid digitalization with the adoption of artificial intelligence, digital twins, and augmented reality in the biopharmaceutical industry are offering immense growth opportunities for biomanufacturing to resolve challenges in producing and supplying biologic medicines. Furthermore, the growing commercialization and adoption of novel biomanufacturing strategies to enhance efficiency and productivity, and reduction in operating costs are positively influencing the growth of the Next-Generation Biomanufacturing market worldwide in the forthcoming years. The increasing investor and government funding are other factors further expanding the next-generation biomanufacturing market.
North America
Europe
Asia-Pacific
Rest of the World
Geographically, the North American Next-Generation Biomanufacturing Market accounted for the largest revenue share in the global market in 2021. This can be attributed to the well-equipped biomanufacturing facilities with advanced infrastructure, strong investments in the biomanufacturing sector, and the presence of several key industry players in the region. The expanding biopharmaceuticals and biologics industry in the North American region is offering huge growth opportunities for the next generation biomanufacturing market, attracting investors to enter this field. The Next-Generation Biomanufacturing Market in Europe is anticipated to account for the second-largest share during the forecast period.
The Asia Pacific Next-Generation Biomanufacturing Market is anticipated to grow at the fastest CAGR during the forecast period. This is attributed to the rising population in countries like China and India. The emerging nations of Asia-Pacific, such as Japan, South Korea, India, Australia, and Singapore, are widely adopting technologically advanced biomanufacturing equipment. The growth in new capacity installations to meet the rising product demand in developing nations of Asia-Pacific is further likely to boost the next-generation biomanufacturing market growth.
The Next-Generation Biomanufacturing Market in Latin America, the Middle East, and Africa is anticipated to account for the least share in the global market during the forecast period owing to the lower adoption of advanced technology.
Major Key Players in the Market
Applikon Biotechnology BV
Thermo Fisher Scientific Inc.
bbi-biotech GmbH
Danaher Corporation
Eppendorf AG
Esco Group of Companies
Meissner Filtration Products, Inc.
Merck KGaA, PBS Biotech, Inc.
Pierre Guerin
Sartorius AG
Shanghai Bailun Biotechnology Co. Ltd
Solaris Biotechnology Srl
GEA Group Aktiengesellschaft
ZETA GmbH
Are some leading companies in the global Next-Generation Biomanufacturing Market. The Next-Generation Biomanufacturing Market has witnessed 115 key developments in biomanufacturing and automation by key companies from acquisitions to partnerships and collaborations, over the past five years.
Notable happenings in the Global Next-Generation Biomanufacturing Market in the recent past:
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
